Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

LenioBio GmbH

LenioBio GmbH_logo
18
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

At LenioBio we are committed to the advancement of trans-formative technology platforms for the discovery, development and synthesis of ‘difficult-to-produce’ proteins unconstrained by the limitations of the cell.

Düsseldorf, Stadt, Nordrhein-Westfalen, Germany

Send a message

Anglais

LenioBio GmbH

Anglais

At LenioBio we are committed to the advancement of transformative technology platforms for the discovery, development and synthesis of ‘difficult-to-produce’ proteins unconstrained by the limitations of the cell.

Our aim is to deliver solutions which will yield greater efficiencies along the whole protein development chain, enabling the relevant sectors to speed up the introduction of proteins that are more effective and less expensive.

Our first product, the cell-free...

See more

At LenioBio we are committed to the advancement of transformative technology platforms for the discovery, development and synthesis of ‘difficult-to-produce’ proteins unconstrained by the limitations of the cell.

Our aim is to deliver solutions which will yield greater efficiencies along the whole protein development chain, enabling the relevant sectors to speed up the introduction of proteins that are more effective and less expensive.

Our first product, the cell-free protein expression kit ALiCE® was launched in October 2018; This eukaryotic kit offers our customers the highest protein yields in a single step than any other cell free expression system currently available. The ALiCE® platform has years of validation as one of the cornerstone protein expression technologies in leading biotech companies.

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

European Innovation Council - Accelerator beneficiaries
This label is a guarantee for investors to discover selected companies benefiting from Business acceleration services provided by the European Commission.
167 Entities